Big Pharma has no interest in doing studies on Ivermectin for Covid

Money corrupts and big drug companies like Pfizer and Merck have no interest in evaluating inexpensive repurposed drugs for treating diseases. The lack of curiosity and dismissal of public interest troubles many, as private actors are not obligated to conduct scientific experiments for public benefit. The NIH is conducting a study on Ivermectin, but their evaluations of repurposed drugs have been slow. This lack of solid data leads to big fights and controversy in the medical industry.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.